We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$209M
Cap. Flow
+$62M
Cap. Flow %
4.13%
Top 10 Hldgs %
53.8%
Holding
1,139
New
71
Increased
183
Reduced
145
Closed
36

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$13.8M
2
MSFT icon
Microsoft
MSFT
+$7.37M
3
TMO icon
Thermo Fisher Scientific
TMO
+$6.07M
4
V icon
Visa
V
+$5.18M
5
ADBE icon
Adobe
ADBE
+$3.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.63M
2
AMZN icon
Amazon
AMZN
+$3.19M
3
TSLA icon
Tesla
TSLA
+$1.89M
4
AMD icon
Advanced Micro Devices
AMD
+$1.46M
5
ABT icon
Abbott
ABT
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 21.59%
3 Consumer Discretionary 19.48%
4 Communication Services 10.64%
5 Healthcare 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVGS icon
851
Navigator Holdings
NVGS
$1.36B
$7.52K ﹤0.01%
900
RWT
852
Redwood Trust
RWT
$580M
$7.52K ﹤0.01%
1,000
NUS icon
853
Nu Skin
NUS
$236M
$7.51K ﹤0.01%
150
BBL
854
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$7.47K ﹤0.01%
175
SWCH
855
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$7.34K ﹤0.01%
470
KW
856
DELISTED
Kennedy-Wilson Holdings
KW
$7.26K ﹤0.01%
500
MFGP
857
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$7.24K ﹤0.01%
2,249
NBIX icon
858
Neurocrine Biosciences
NBIX
$15.7B
$7.21K ﹤0.01%
75
BGC icon
859
BGC Group
BGC
$5.76B
$7.2K ﹤0.01%
3,000
IONS icon
860
Ionis Pharmaceuticals
IONS
$10.1B
$7.12K ﹤0.01%
150
ARNC
861
DELISTED
Arconic Corporation
ARNC
$7.05K ﹤0.01%
370
AVNS
862
DELISTED
Avanos Medical
AVNS
$7.04K ﹤0.01%
212
GDS icon
863
GDS Holdings
GDS
$6.69B
$6.96K ﹤0.01%
+85
New +$6.81K
STNE icon
864
StoneCo
STNE
$2.24B
$6.88K ﹤0.01%
+130
New +$6.21K
BCLI
865
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$6.77K ﹤0.01%
+27
New +$5.53K
NKLA
866
DELISTED
Nikola Corporation Common Stock
NKLA
$6.76K ﹤0.01%
11
+5
+83% +$5.82K
BIMI
867
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$6.72K ﹤0.01%
80
MCK icon
868
McKesson
MCK
$104B
$6.7K ﹤0.01%
45
SCCO icon
869
Southern Copper
SCCO
$177B
$6.66K ﹤0.01%
160
ASIX icon
870
AdvanSix
ASIX
$445M
$6.62K ﹤0.01%
514
-143
-22% -$1.78K
XOMA
871
DELISTED
Xoma
XOMA
$6.59K ﹤0.01%
350
GOLF icon
872
Acushnet Holdings
GOLF
$5.08B
$6.59K ﹤0.01%
196
SRNE
873
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$6.47K ﹤0.01%
580
JNPR
874
DELISTED
Juniper Networks
JNPR
$6.45K ﹤0.01%
300
MAT icon
875
Mattel
MAT
$4.33B
$6.43K ﹤0.01%
550

Similar funds

RBC Europe's Q3 2020 Portfolio in Review

As of Q3 2020, RBC Europe held 1,139 positions worth $1.5B, up 16% from $1.29B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

RBC Europe deployed $62M of net new capital in Q3 2020, opening 71 new positions and adding to 183 existing holdings. Its largest new stake was Sprott Physical Silver Trust: 31,220 shares worth $258K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $4.63M trimmed.

  • RBC Europe's largest Q3 2020 buy was Sprott Physical Silver Trust: 31,220 shares worth $258K.
  • RBC Europe added most to Applied Materials in Q3 2020, an estimated $13.8M increase.
  • RBC Europe's biggest Q3 2020 reduction was Apple, cutting an estimated $4.63M.
  • RBC Europe fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2020, selling an estimated $196K.
  • RBC Europe's ten largest holdings make up 54% of its $1.5B portfolio in Q3 2020.
  • RBC Europe opened 71 new positions and closed 36 in Q3 2020.
  • RBC Europe's portfolio value rose 16% quarter-over-quarter to $1.5B.

Based on RBC Europe's 13F filing for Q3 2020, filed 9 Nov 2023.